Cumberland Pharmaceuticals (CPIX) Reports Q3 EPS of $0.04

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.04, versus $0.10 reported last year. Revenue for the quarter came in at $7.9 million, versus $9.73 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Morgan Stanley Resumes Urban Outfitters, Inc. (URBN) at Overweight
• Mizuho Resumes Spire (SR) at Outperform